Steve Tregay (Mission BioCapital)

Tout­ing close ties to biotech in­cu­ba­tors, Mis­sion Bio­Cap­i­tal grabs $275M to help launch star­tups

Be­fore mov­ing to shiny new of­fices on their ven­ture dimes, many biotech star­tups trace their be­gin­nings back to shared lab­o­ra­to­ry spaces like Lab­Cen­tral and Bi­o­Labs.

As the in­flux of VC dol­lars push more sea­soned play­ers to­ward ear­li­er stages of in­vest­ing, Mis­sion Bio­Cap­i­tal — the in­vest­ment firm be­hind some of the more promi­nent in­cu­ba­tor fa­cil­i­ties — has re­fu­eled with an­oth­er $275 mil­lion to place a fresh set of bets.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.